gland pharma glp-1 manufacturing capacity india FY25 Results: Strong Margins, 31 Product Launches | Harshal Jain posted on the topic Brookfield, EQT close in on
Description
What's in it
Trending GLP-1s (like Ozempic) are now raising red flags for nAMD.
With the rise of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro, conversations surrounding their inclusion in employee benefits programs are expanding in new directions.
But once that pharmacological scaffolding is gone, the old dynamics often roar backstronger than before.
Ron Grisanti, D.C., D.A.B.C.O., D.A.C.B.N., M.S., DIANM, CFMP is the founder of Functional Medicine University and author of The Medical Detective Reports. Read his full bio ...
)
GLP-1 therapy isn't necessarily lifelong for everyone
